Journal of the American Academy of Dermatology · 2018 · 13 citations · 32 references
MedicineOncologyPharmacotherapyCutaneous OncologyOncology Medication SafetyOncology PharmacotherapyCancer Survival AnalysisMalignant NeoplasmsMelanocytic LesionsMelanocytic TumorsMelanoma PharmacotherapyAspirin ChemopreventionAspirin ResponseMalignant Melanocytic TumorsMelanocytic Tumor PrognosisOverall Mortality
32
Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2017 · 15K citations · Full text
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
James Larkin, Vanna Chiarion‐Sileni, René González et al. · New England Journal of Medicine · 2015 · 8.1K citations · Full text
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
Paul B. Chapman, Axel Hauschild, Caroline Robert et al. · New England Journal of Medicine · 2011 · 7.7K citations · Full text
Pembrolizumab versus Ipilimumab in Advanced Melanoma
Caroline Robert, Jacob Schachter, Georgina V. Long et al. · New England Journal of Medicine · 2015 · 5.8K citations · Full text